Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Marshall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, Hutchison J, Mehta S, Menon K, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative.

Crit Care. 2016 Mar 30;20:75. doi: 10.1186/s13054-016-1230-8.

2.

Critical care capacity in Canada: results of a national cross-sectional study.

Fowler RA, Abdelmalik P, Wood G, Foster D, Gibney N, Bandrauk N, Turgeon AF, Lamontagne F, Kumar A, Zarychanski R, Green R, Bagshaw SM, Stelfox HT, Foster R, Dodek P, Shaw S, Granton J, Lawless B, Hill A, Rose L, Adhikari NK, Scales DC, Cook DJ, Marshall JC, Martin C, Jouvet P; Canadian Critical Care Trials Group; Canadian ICU Capacity Group.

Crit Care. 2015 Apr 1;19:133. doi: 10.1186/s13054-015-0852-6.

3.

Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study.

Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NK; Canadian Critical Care Trials Group H1N1 Collaborative.

BMC Nephrol. 2013 Jun 13;14:123. doi: 10.1186/1471-2369-14-123.

4.

The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection.

Muscedere J, Ofner M, Kumar A, Long J, Lamontagne F, Cook D, McGeer A, Chant C, Marshall J, Jouvet P, Fowler R; ICU-FLU Group; Canadian Critical Care Trials Group.

Chest. 2013 Jul;144(1):39-47. doi: 10.1378/chest.12-1861.

PMID:
23392627

Supplemental Content

Loading ...
Write to the Help Desk